What Is Drawing Fresh Attention To Integer Holdings (ITGR)?

Integer Holdings (ITGR) has drawn attention after recent share gains left the stock around $126.61, with investors weighing its solid year-to-date and past 3 months returns against its current value score.

Recent trading has been relatively steady, yet the strong 90 day share price return of 35.69% and year to date share price return of 64.90% show that momentum has been building. The 3 year total shareholder return of 66.40% points to a solid longer term record.

Scan other momentum stories like Integer Holdings by checking the hand picked 29 high quality undervalued stocks that still have valuation support behind their recent strong moves.

Integer Holdings now looks like a solid medical device contractor paired with a fast climbing share price. The harder question is whether that quality is already fully reflected in today’s US$126.61 tag.

Most Popular Narrative: 4% Overvalued

Integer Holdings is trading at $126.61 against a widely followed fair value anchor of $121.80. This frames the current price as slightly ahead of that narrative, while still close enough for execution to matter more than small price gaps.

The main thing that has to go right is that Integer Holdings converts its larger pipeline in electrophysiology, structural heart, neurovascular and neuromodulation into launched programs that offset current guidance cuts and inventory adjustments, while restoring margins closer to prior targets through the Integer Production System and scale efficiencies.

See why 6 investors see Integer Holdings as 4% overvalued.

Result: Fair Value of $121.80 (OVERVALUED)

Still, Integer Holdings faces real pressure if weaker adoption of new products persists or if concentrated OEM customers continue trimming electrophysiology orders and inventories.

Find out about the key risks to this Integer Holdings narrative.

Another View: Integer Holdings Through A Cash Flow Lens

That analyst fair value anchor of $121.80 is only one yardstick. Our DCF model points to a future cash flow value of $167.57, which screens Integer Holdings as undervalued despite a P/E of 33.5x. Two frameworks, two different answers. Which one lines up better with your own assumptions?

To understand how those cash flows translate into that $167.57 estimate, take a closer look at how the SWS DCF model weighs growth, margins and risk for Integer Holdings, then compare it to the analyst target framework. Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Integer Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 29 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

The story so far presents Integer Holdings as a blend of opportunity and challenge. Consider reviewing the numbers promptly and stress testing the assumptions yourself using the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Integer Holdings?

If Integer Holdings has sharpened your thinking, do not stop here. Fresh ideas often show up where strong fundamentals, resilient cash flows and disciplined capital returns intersect.

• Target reliable cash generation and income by reviewing companies in the 8 dividend fortresses that might complement a growth focused portfolio.
• Hunt for quality businesses priced below their fundamentals by scanning the 29 high quality undervalued stocks before momentum fully catches up.
• Prioritise capital protection and smoother returns by checking the 31 resilient stocks with low risk scores so you are not missing sturdier options while headlines chase excitement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com